tiprankstipranks
Advertisement
Advertisement

CTMX Stock Latest News

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
Market News3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
6d ago
COYA
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
PremiumThe Fly
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
6d ago
CTMX
CytomX Therapeutics Raises $234 Million in Equity Offering
PremiumCompany Announcements
CytomX Therapeutics Raises $234 Million in Equity Offering
10d ago
8K
CTMX
CytomX Therapeutics price target raised to $16 from $10 at Barclays
PremiumThe Fly
CytomX Therapeutics price target raised to $16 from $10 at Barclays
10d ago
CTMX
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
PremiumThe Fly
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
11d ago
CTMX
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
PremiumThe FlyCytomX Therapeutics price target raised to $15 from $10 at Guggenheim
11d ago
CTMX
CytomX Therapeutics 45.9M share Secondary priced at $5.30
Premium
The Fly
CytomX Therapeutics 45.9M share Secondary priced at $5.30
11d ago
CTMX
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
Premium
The Fly
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
12d ago
BA
BW
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
PremiumThe Fly
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
12d ago
CTMX
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
PremiumCompany Announcements
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
12d ago
CTMX
CytomX Therapeutics announces $250M common stock offering
PremiumThe Fly
CytomX Therapeutics announces $250M common stock offering
13d ago
CTMX
CytomX Therapeutics files automatic mixed securities shelf
PremiumThe Fly
CytomX Therapeutics files automatic mixed securities shelf
13d ago
CTMX
Varseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
PremiumRatingsVarseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
13d ago
CTMX
CytomX Therapeutics price target raised to $17 from $10 at H.C. Wainwright
Premium
The Fly
CytomX Therapeutics price target raised to $17 from $10 at H.C. Wainwright
13d ago
CTMX
Midday Fly By: Meta said to eye job cuts, Dollar Tree up after earnings
Premium
The Fly
Midday Fly By: Meta said to eye job cuts, Dollar Tree up after earnings
13d ago
JD
MU
CytomX Therapeutics upgraded to Overweight at JPMorgan after late-line CRC data
PremiumThe Fly
CytomX Therapeutics upgraded to Overweight at JPMorgan after late-line CRC data
13d ago
CTMX
CytomX Therapeutics upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
CytomX Therapeutics upgraded to Overweight from Neutral at JPMorgan
13d ago
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Oppenheimer
PremiumThe Fly
CytomX Therapeutics price target raised to $12 from $10 at Oppenheimer
13d ago
CTMX
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
PremiumTipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
13d ago
CTMX
NSRX
Options Volatility and Implied Earnings Moves Today, March 16, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 16, 2026
13d ago
NIU
AGEN
CytomX Therapeutics announces Phase 1 expansion data on varsetatug masetecan
Premium
The Fly
CytomX Therapeutics announces Phase 1 expansion data on varsetatug masetecan
13d ago
CTMX
CytomX Therapeutics reports Q4 EPS (22c), consensus (9c)
Premium
The Fly
CytomX Therapeutics reports Q4 EPS (22c), consensus (9c)
13d ago
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >